Preferential drug program for patients within the federal project for control of cardiovascular diseases: implementation strategy, results and prospects

A serious barrier to the widespread practical implementation of evidence therapy for cardiovascular diseases is financial constraints, which exacerbate low patient complience and affect inequality in cardiovascular health indicators population, increasing morbidity and mortality. At the level of healthcare systems in different countries, drug provision is recognized as an effective tool for increasing patient adherence to treatment and improving clinical outcomes. The problematic article discusses the preferential drug program within the federal project for control of cardiovascular diseases. The key principles for forming priority groups, mechanisms and stages of program implementation are outlined. Monitoring the program’s effectiveness made it possible to identify reserves and prospects for its further strategic development.

Authors

Institutions

Publication Details

Journal
Russian Journal of Cardiology
Published
2025-08-08
DOI
https://doi.org/10.15829/1560-4071-2025-6391
Citations
2
Primary Topic
Cardiac Health and Mental Health
Type
article
Field-Weighted Citation Impact
2.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preferential drug program for patients within the federal project for control of cardiovascular diseases: implementation strategy, results and prospects

Е. А. Медведева, S. V. Villevalde, Е. V. Shlyakhto, E. G. Kamkin et al.
2 citations
Russian Journal of Cardiology
Cardiac Health and Mental Health
2.78
article

Preferential drug program for patients within the federal project for control of cardiovascular diseases: implementation strategy, results and prospects

Е. А. Медведева, S. V. Villevalde, Е. V. Shlyakhto, E. G. Kamkin, A. E. Soloveva, А. С. Старовойтова, E.V. Karakulina, A. N. Yakovlev, А. А. Федоренко, Елена Астапенко, Е П Мазыгула, Ksenia Zagorodnikova, Н. Э. Звартау, Andrey Moskalev, V. A. Gulshina, Z. N. Tautova
article en
2 citations

Abstract

A serious barrier to the widespread practical implementation of evidence therapy for cardiovascular diseases is financial constraints, which exacerbate low patient complience and affect inequality in cardiovascular health indicators population, increasing morbidity and mortality. At the level of healthcare systems in different countries, drug provision is recognized as an effective tool for increasing patient adherence to treatment and improving clinical outcomes. The problematic article discusses the preferential drug program within the federal project for control of cardiovascular diseases. The key principles for forming priority groups, mechanisms and stages of program implementation are outlined. Monitoring the program’s effectiveness made it possible to identify reserves and prospects for its further strategic development.

Russian Journal of CardiologyVol. 30(6)
Federal Almazov North-West Medical Research Centre (RU), Ministry of Health of the Russian Federation (RU), Scientific Research Institute of Healthcare Organization and Medical Management (RU)
Openalex Percentile: Top 8%
Cardiac Health and Mental Health
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.